Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRICKLE
2013-004200-19Phase 2Terminated
- Sponsor
- Cambridge University Hospitals NHS Foundation Trust
- Start
- Jun 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of paclitaxel and gemcitabine in pancreatic cancer (PC) and Pancreatic carcinoma (PC), sponsored by Cambridge University Hospitals NHS Foundation Trust. Primary endpoint: Resectability rate. Started Jun 2014; status: terminated.
02
Drugs
paclitaxelgemcitabine
03
Conditions
pancreatic cancer (PC)Pancreatic carcinoma (PC)
Beyond the preview
Go deeper on 2013-004200-19.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-004200-19.